Device Recall Symbiq One Channel Infuser 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Hospira Inc. 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    63993
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-0353-2017
  • 사례 시작날짜
    2013-02-05
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2016-12-15
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • 데이터 추가 비고
    Pump, infusion - Product Code FRN
  • 원인
    Hospira has received reports of malfunction s205 backup battery failure alarms in symbiq v3.13 pumps. this issue to an incorrect installation of components on some of the power supply controller (psc) boards distributed prior to september 2012. on pumps where incorrect installation of components has occurred, the backup battery power discharges and subsequently, the battery cannot be charged. because of the battery depletion, or lack of charge, a visual and audible warning alarm, s205, is displayed. an s205 alarm is intended to notify the customer that the coin call battery, powering the backup buzzer, may need to be charged or replaced.
  • 조치
    Hospira sent an Urgent Field Device Correction letter dated Feburay 5, 2013, to all affected customers. Hospira has implemented a correction to the manufacturing process to address this issue. Symbiq v3.13 pumps that have been shipped from Hospira since September 2012 and pumps that were upgraded to v3.13 in the Field after September 2012 are not impacted by this issue. If you are unsure of when you were shipped Symbiq v3.13 pumps or when your devices were upgraded, contact Hospira. Please complete the attached reply form and return it via fax number or e-mail address on the form, even if you do not currently have the impacted infuser. lease contact Stericycle at 1-866-201-9072 (M-F, Bam - 5pm EST) to obtain additional copies of the reply form. If you have further distributed these devices, please notify your accounts who may have received these infusers from you and ask them to contact Stericycle at 1-866-201-9072 (M-F, 8am- 5pm EST) to receive a reply form.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Worldwide Distribution - US (nationwide) and Canada
  • 제품 설명
    Symbiq One Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List number 16026. Note that Hospira retired this pump June 30, 2015. || The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood, and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Hospira Inc., 275 N Field Dr, Lake Forest IL 60045-2579
  • 제조사 모회사 (2017)
  • Source
    USFDA